BRD9 and leukemia: However, of interest and unlike previous reports for MLL-driven leukemias32,33, our Npm1c and Flt3-ITD model did not show vulnerability to Brd9 (ncBAF) disruption, highlighting that different leukemia mutations produce specific chromatin states that are variably dependent on individual chromatin factors.